Citadel Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $277K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $640K | Buy |
|
|||||
|
2024
Q1 | $249K | Sell |
|
|||||
|
2023
Q4 | $3.11M | Buy |
|
|||||
|
2023
Q3 | $1.45M | Buy |
|
|||||
|
2023
Q2 | $1.5M | Buy |
|
|||||
|
2023
Q1 | $433K | Sell |
|
|||||
|
2022
Q4 | $3.03M | Sell |
|
|||||
|
2022
Q3 | $8.91M | Sell |
|
|||||
|
2022
Q2 | $10.6M | Buy |
|
|||||
|
2022
Q1 | $13M | Buy |
|
|||||
|
2021
Q4 | $956K | Buy |
|
|||||
|
2021
Q3 | $1.38M | Sell |
|
|||||
|
2021
Q2 | $4.04M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $334K | Sell |
|
|||||
|
2020
Q3 | $6.5M | Buy |
|
|||||
|
2020
Q2 | $375K | Sell |
|
|||||
|
2020
Q1 | $234K | Sell |
|
|||||
|
2019
Q4 | $487K | Sell |
|
|||||
|
2019
Q3 | $2.12M | Buy |
|
|||||
|
2019
Q2 | $1.86M | Sell |
|
|||||
|
2019
Q1 | $3.25M | Buy |
|
|||||
|
2018
Q4 | $233K | Sell |
|
|||||
|
2018
Q3 | $2.9M | Sell |
|
|||||
|
2018
Q2 | $4.52M | Buy |
|
|||||
|
2018
Q1 | $2.61M | Buy |
|
|||||
|
2017
Q4 | $1.27M | Buy |
|
|||||
|
2017
Q3 | – | Hold |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $213K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $757K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $846K | Buy |
|
|||||
|
2014
Q3 | $533K | Sell |
|
|||||
|
2014
Q2 | $4.26M | Buy |
|
|||||
|
2014
Q1 | $2.54M | Buy |
|